2-[(4,6-Dimethoxypyrimidin-2-yl)oxy]benzoic acid, 95.0%, 250mg

(2S,2'S,3S,3'S)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 50mg

3-Ethoxy-2,4-difluorobenzyl bromide, 5g

2,5-Cyclohexadiene-1,4-dione, 2-(2,5-dichlorophenyl)-, 98%, 250mg

2-(P-tolyl)butanoic acid, 95%, 50mg

(2-(Methylsulfonamido)phenyl)boronic acid, 95.0%, 1g

2-(Benzyloxy)-1-bromo-3-chlorobenzene, 98%, 1g

Glass syringe with Luer connection (glass), 5 ml, 1 piece

Propyl Vinyl Ether (stabilized with KOH)>97.0%(GC)25mL

(S)-tert-Butyl (pyrrolidin-2-ylmethyl)carbamatehydrochloride, 95.0%, 1g

7-(Trifluoromethyl)-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)oxazole, 97%, 500mg

TERT-BUTYL 7-OXO-2,8-DIAZASPIRO[5.5]UNDECANE-2-CARBOXYLATE, 98+%, 1g